Showing results (31-40 of 829) with videos related to
Sort By:
Pageof 83
Diabetes Care|April 29, 2006
Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathyPeter Rossing, Kasper Rossing, Peter Gaede, et al.Diabetes Care|April 29, 2011
Vitamin D levels, microvascular complications, and mortality in type 1 diabetesChristel Joergensen, Peter Hovind, Anne Schmedes, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2020
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetesViktor Rotbain Curovic, Simone Theilade, Signe Abitz Winther, et al.Cardiovascular Diabetology|July 13, 2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.Annals of Translational Medicine|May 14, 2021
A narrative review of new treatment options for chronic kidney disease in type 2 diabetesFrederik Persson, Rikke Borg, Peter RossingJournal of Nephrology|June 1, 2020
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?Nete Tofte, Frederik Persson, Peter RossingNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Optimal dose of losartan for renoprotection in diabetic nephropathySteen Andersen, Peter Rossing, Tina R Juhl, et al.Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.Diabetes Care|July 10, 2009
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuriaFrederik Persson, Peter Rossing, Henrik Reinhard, et al.Journal of Diabetes and Its Complications|May 1, 2020
Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuriaNiels Sondergaard Heinrich, Bernt Johan von Scholten, Henrik Reinhard, et al.Pageof 83